top of page
News, Events and Updates
Search
Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference
9 hours ago
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025
1 day ago
Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease
5 days ago
Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group
Oct 29
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
